מצגת של PowerPoint -...
Transcript of מצגת של PowerPoint -...
![Page 1: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/1.jpg)
![Page 2: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/2.jpg)
![Page 3: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/3.jpg)
Yevgeni TomsovMy Dad
![Page 4: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/4.jpg)
![Page 5: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/5.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
1 million people!
![Page 6: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/6.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
61 million people!
![Page 7: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/7.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
![Page 8: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/8.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Suffer from baldness symptoms
Don't suffer
55%45%
N=470
Male pattern baldness by the age of 35
Practices
![Page 9: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/9.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Effective Not effective
How effective are the solutions available?
7%
93%
N=470Practices
![Page 10: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/10.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Hair tattoo
© Jill Carlson, flickr © Hagai Dekel, ynet
#trumpcat
![Page 11: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/11.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
SurgicalNon-surgical
![Page 12: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/12.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Non-surgical treatment
Oraldirect27.5%
Topicalindirect
28.2%Other44.3%
Relevant Research, Inc.International Society of Hair Restoration Surgery2014
![Page 13: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/13.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Non-surgical treatment
Relevant Research, Inc.International Society of Hair Restoration Surgery2014
Topicalindirect
![Page 14: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/14.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Non-surgical treatment
Relevant Research, Inc.International Society of Hair Restoration Surgery2014
Oraldirect Side effects
![Page 15: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/15.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Testosterone Dihydrotestosterone
5α-reductase
The cause
![Page 16: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/16.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Dihydrotestosterone (DHT)
©http://gondronglagi.blogspot.co.il/2013/10/ingin-gondrong-lagi.html
![Page 17: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/17.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
SurgicalNon-surgical
![Page 18: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/18.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
NADH/NADPH NAD+/NADP+
3α-hydroxysteroid dehydrogenase
DHT 3α-Androstanediol
Human 3-alpha hydroxysteroid ... The Journal of Steroid Biochemistry and Molecular Biology 141, 135-143.
![Page 19: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/19.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Bacillus subtilis: 15.4%
The most widespread bacteria on the scalp
Secretes
Roia, F.C.; Vanderwyk, R., R. W.. Journal of The Society of Cosmetic Chemists. 1969, 20, 113-134.
![Page 20: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/20.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Yes No/don’t know/other
Would balding men use a product which includes genetically modified bacteria?
22%
78%
N=470Practices
![Page 21: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/21.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
NADH/NADPH NAD+/NADP+
3α-hydroxysteroid dehydrogenase
DHT 3α-Androstanediol
Human 3-alpha hydroxysteroid ... The Journal of Steroid Biochemistry and Molecular Biology 141, 135-143.
![Page 22: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/22.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
For B. subtilis
![Page 23: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/23.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
NADH/ NAD+/
3α-hydroxysteroid dehydrogenase
DHT 3α-Androstanediol
NADPH NADP+
Human 3-alpha hydroxysteroid ... The Journal of Steroid Biochemistry and Molecular Biology 141, 135-143.
![Page 24: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/24.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.
![Page 25: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/25.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.
![Page 26: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/26.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.
![Page 27: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/27.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.
![Page 28: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/28.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.
![Page 29: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/29.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.
NADPH
NADPH
NADPH
NADPH
NADPH
NADPH
NADPH
![Page 30: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/30.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
For BL21
For MG1655
![Page 31: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/31.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
![Page 32: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/32.jpg)
Bald DHT Chassis Cofactor Results Comb Practices
For MG1655
For B. subtilis
![Page 33: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/33.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Secretion Assay Principle
MIT OpenCourseWare
evrogen.com
![Page 34: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/34.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Secretion with signal peptide aprE from B. subtilis
200
400
600
800
1000
1200
1400
1600
1800
2000
0 1 2 3 4 5 6
No
rmalized
flu
ore
scen
ce (
a.u
.)
Time (hour)
mCherry signal peptide+mCherry
BBa_K1674000
![Page 35: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/35.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Activity assay principle
MIT OpenCourseWare
George H. Patterson et al. PNAS 2000;97:5203-5207
In silico model:
![Page 36: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/36.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Activity of 3αHSD in E. coli BL21 lysate, DHT=40 µM
6000
8000
10000
12000
14000
16000
18000
30 300
Flu
ore
sc
en
ce
(a
.u.)
Time (min)
3αHSD no 3αHSD
BBa_K1674001
In silico model:
![Page 37: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/37.jpg)
Bald DHT Chassis Cofactor Results Comb Practices
Reaction rate of NADPH consumption in different DHT concentrations
0.26
0.28
0.3
0.32
0.34
0.36
0.38
0.4
0 20 40 60 80
Reacti
on
Rate
(1
/se
c)
DHT (µM)
3αHSD no 3αHSD
BBa_K1674001
In silico model:
![Page 38: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/38.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Cofactor assay principle
Extracellular Intracellular
MIT OpenCourseWare
![Page 39: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/39.jpg)
Bald DHT Chassis Cofactor Results Comb Practices
Normalized NADPH fluorescence vs. Time for E. coli BL21 strains
BBa_K1674004
0
10000
20000
30000
40000
50000
60000
70000
0 4 8 12 16 20 24
Flu
ore
sc
en
ce
/OD
(a.u
.)
Time (hour)
BL21 wildtype BL21 with zwf
0
5000
10000
15000
20000
25000
30000
35000
Flu
ore
scen
ce/O
D (
a.u
.)
BL21 wildtype BL21 with zwf
![Page 40: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/40.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Combined experiment principle
ExtracellularIntracellular
MIT OpenCourseWare
![Page 41: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/41.jpg)
Bald DHT Chassis Cofactor Results Comb Practices
Reaction rate of consumption of NADPH from enriched supernatant
0.1
0.11
0.12
0.13
0.14
0.15
0.16
0.17
0.18
0.19
3αHSD no 3αHSD
Re
acti
on
Rat
e (
1/s
ec)
Combined experiment
BBa_K1674001 BBa_K1674004
![Page 42: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/42.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
?
![Page 43: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/43.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Clean
Uniform applicationSafe
Reusable
The CombDesign
![Page 44: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/44.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
![Page 45: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/45.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
![Page 46: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/46.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
![Page 47: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/47.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
![Page 48: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/48.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
Optimal storage conditions:-18°C in 80% glycerol medium
Practices
![Page 49: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/49.jpg)
Bald DHT Chassis Cofactor Results Comb Vision
![Page 50: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/50.jpg)
Benefits of our solution
Bald DHT Chassis Cofactor Results Comb Vision
Purified enzyme solution vs.bacterial secretion
NADPH User experience
![Page 51: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/51.jpg)
Achievements
New Application BioBricks Design
Modeling Collaboration Practices
![Page 52: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/52.jpg)
Our Mentors:Dr. Roee AmitDr. Orna AtarNoa KatzInbal VakninLior LevyAlex Ereskovsky
![Page 53: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/53.jpg)
![Page 54: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/54.jpg)
![Page 55: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,](https://reader034.fdocuments.us/reader034/viewer/2022050311/5f73b3aba783d474c623f266/html5/thumbnails/55.jpg)